VaxGen

This is the limited version of the VaxGen company profile: Join LinkedIn or Sign In to see more information.

VaxGen, Inc., a biopharmaceutical company, engages in the development, manufacture, and commercialization of biologic products for the prevention and treatment of human infectious disease. It focuses on the development and commercialization of biologic products to counter potential bioterrorism threats, primarily vaccines for the long-term prevention of anthrax and smallpox. The company, in collaboration with the Chemo-Sero-Therapeutic Research Institute of Japan, is developing LC16m8, a smallpox vaccine candidate. VaxGen was founded in 1995 and is based in South San Francisco, California.

Your Connections to VaxGen

To see how you’re connected: Join Now or Sign In

Popular Profiles at VaxGen

In partnership with BusinessWeek

Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.

This LinkedIn Company Profile was created by LinkedIn and is about VaxGen. This page is not endorsed by or affiliated with VaxGen. For questions regarding LinkedIn Company Profiles, contact us.

VaxGen (VXGN) full company profile, stock quotes, financial statements and more.

Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions